Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis
Surgical Endoscopy · 2026
DOI: 10.1007/s00464-025-12446-1 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Surgical Endoscopy, 2026. Verfasst von Razan Aburumman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA. Razanaburumman@outlook.com. Hauptthemen laut MEDLINE: Liver Cirrhosis, Endoscopy, Digestive System, Postoperative Hemorrhage, Endoscopic Mucosal Resection. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Esophagogastroduodenoscopy (EGD) with endoscopic mucosal resection (EMR) is commonly used for evaluating and managing gastrointestinal lesions. This study aimed to assess the 30-day risk of bleeding and other adverse outcomes following EGD-EMR in cirrhotic patients. METHODS: This retrospective cohort study utilized data from the US Collaborative Network to evaluate bleeding risk following EGD-EMR in cirrhotic patients. One-to-one propensity score matching was performed, with the primary outcome being bleeding within 30 days post-procedure. RESULTS: Each cohort included 1,045 patients. Cirrhotic patients had higher risk of post-EGD-EMR bleeding (OR 1.65, 95% CI 1.21-2.25, P = 0.002) and were more likely to require a blood transfusion (OR 2.54, 95% CI 1.21-5.31, P = 0.011). However, ICU admissions (OR 1.33, P = 0.29) and endoscopic reinterventions (OR 1.31, P = 0.25) did not differ significantly. Patients with decompensated cirrhosis had a higher bleeding risk compared to controls (OR 1.62, 95% CI 1.05-2.51, P = 0.03), while those with compensated cirrhosis showed no increased risk (OR 1.16, P = 0.55). DISCUSSION: This study found increased post-procedural bleeding in cirrhotic patients, particularly those with decompensated cirrhosis. Careful pre-procedural management of coagulopathy is crucial to minimize complications in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA. Razanaburumman@outlook.com.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Razanaburumman@outlook.com.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
- Division of Gastroenterology and Hepatology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
ORCID-Profile: Razan Aburumman
Zitieren
APA
Aburumman, R., Alsakarneh, S., & Singla, S. (2026). Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis. Surgical Endoscopy. https://doi.org/10.1007/s00464-025-12446-1
Vancouver
Aburumman R, Alsakarneh S, Singla S. Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis. Surgical Endoscopy. 2026. doi:10.1007/s00464-025-12446-1
BibTeX
@article{Aburumman2026,
author = {Aburumman, Razan and Alsakarneh, Saqr and Singla, Sumit},
title = {Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis},
journal = {Surgical Endoscopy},
year = {2026},
doi = {10.1007/s00464-025-12446-1}
}
EUVIMED